BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang C, Liu F, Liu W, Cao G, Liu J, Huang S, Zhu M, Tu C, Wang J, Xiong B. Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia. Int J Cardiol. 2020;. [PMID: 32979425 DOI: 10.1016/j.ijcard.2020.09.048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Polito MV, Silverio A, Bellino M, Iuliano G, Di Maio M, Alfano C, Iannece P, Esposito N, Galasso G. Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect? Cardiol Ther 2021. [PMID: 34191268 DOI: 10.1007/s40119-021-00232-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Guglin M, Ballut K, Ilonze O, Jones M, Rao R. Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020. Heart Fail Rev 2021. [PMID: 34215924 DOI: 10.1007/s10741-021-10129-2] [Reference Citation Analysis]
3 Dayaramani C, De Leon J, Reiss AB. Cardiovascular Disease Complicating COVID-19 in the Elderly. Medicina (Kaunas) 2021;57:833. [PMID: 34441038 DOI: 10.3390/medicina57080833] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gragnano F, Cesaro A, Pelliccia F, Calabrò P. Multimodality evaluation of cardiac injury in COVID-19: Getting to the heart of the matter. Int J Cardiol 2021;339:243-5. [PMID: 34298070 DOI: 10.1016/j.ijcard.2021.07.031] [Reference Citation Analysis]
5 Abate SM, Mantefardo B, Nega S, Chekole YA, Basu B, Ali SA, Taddesse M. Global burden of acute myocardial injury associated with COVID-19: A systematic review, meta-analysis, and meta-regression. Ann Med Surg (Lond) 2021;68:102594. [PMID: 34336202 DOI: 10.1016/j.amsu.2021.102594] [Reference Citation Analysis]
6 Veronese G, Winterton D, Ammirati E. Myocardial injury in COVID-19: When observations become reality. Int J Cardiol 2021;323:295-6. [PMID: 33122016 DOI: 10.1016/j.ijcard.2020.10.061] [Reference Citation Analysis]
7 Veronese G, Ammirati E, Chen C, Klingel K, Suzuki M, Okumura T, Maisch B, Zuo H, Ni L, Jiang J, Zhang J, Wang H, Zhou N, Tschope C, Cooper LT, Wang DW. Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis. Int J Cardiol 2021;324:131-8. [PMID: 33122017 DOI: 10.1016/j.ijcard.2020.10.063] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cosgun MS. Bilirubin levels as an independent predictor of myocarditis in patients with COVID-19. Egypt Heart J 2021;73:108. [PMID: 34928467 DOI: 10.1186/s43044-021-00234-w] [Reference Citation Analysis]
9 Ashraf H, Soleimani A, Kazemi saeid A, Sadat Naseri A, Majidi F, Peirovi N, Karbalai Saleh S. Troponin I biomarker as a strong prognostic factor for predicting COVID-19 mortality: A systematic review. World J Meta-Anal 2021; 9(4): 342-352 [DOI: 10.13105/wjma.v9.i4.342] [Reference Citation Analysis]
10 Maestrini V, Birtolo LI, Francone M, Galardo G, Galea N, Severino P, Alessandri F, Colaiacomo MC, Cundari G, Chimenti C, Lavalle C, Ciardi M, Palange P, Deales A, d'Ettorre G, Mastroianni CM, Catalano C, Ruberto F, Pugliese F, d'Amati G, Fedele F, Mancone M; Policlinico Umberto I COVID-19 Group. Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up. Int J Cardiol 2021;339:235-42. [PMID: 34224766 DOI: 10.1016/j.ijcard.2021.06.056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kounis NG, Koniari I, Gogos C, Assimakopoulos SF. Ηypercoagulation and myocardial injury as risk factors for mortality in patients with COVID-19 pneumonia. Am J Emerg Med 2021;47:313-4. [PMID: 33494959 DOI: 10.1016/j.ajem.2021.01.035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wang CS, Gao Y, Kang K, Fei DS, Meng XL, Liu HT, Luo YP, Yang W, Dai QQ, Gao Y, Zhao MY, Yu KJ. Standardization of critical care management of non-critically ill patients with COVID-19 . World J Clin Cases 2021; 9(12): 2696-2702 [PMID: 33969052 DOI: 10.12998/wjcc.v9.i12.2696] [Reference Citation Analysis]
13 Li Y, Deng Y, Ye L, Sun H, Du S, Huang H, Zeng F, Chen X, Deng G. Clinical Significance of Plasma D-Dimer in COVID-19 Mortality. Front Med (Lausanne) 2021;8:638097. [PMID: 34113629 DOI: 10.3389/fmed.2021.638097] [Reference Citation Analysis]
14 Qin R, He L, Yang Z, Jia N, Chen R, Xie J, Fu W, Chen H, Lin X, Huang R, Luo T, Liu Y, Yao S, Jiang M, Li J. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis. Clin Rev Allergy Immunol 2022. [PMID: 35040086 DOI: 10.1007/s12016-021-08908-8] [Reference Citation Analysis]